Kellerhals Carrard advised Broadview Ventures and Panakes Partners in leading the EUR 44 million Series B financing round of CorFlow Therapeutics. This round also includes participation from Merieux Equity Partners, Laerdal Million Lives Fund, Wellington Partners,
Advestra advised Galderma on its inaugural bonds in the aggregate principal amount of CHF 500 million. The payment date of the bonds is September 27, 2024. The bonds will be listed on the SIX Swiss Exchange and are
Walder Wyss advised the shareholders of Saiba Animal Health in the sale of all shares to the biopharmaceutical company Boehringer Ingelheim. With the acquisition, Boehringer Ingelheim strengthens its animal health research and development (R&
Vischer advised Haya Therapeutics, a Swiss biotechnology company pioneering precision RNA-guided regulatory genome targeting therapeutics, which announced a multi-year agreement with Eli Lilly and Company to apply Haya’s advanced RNA-guided regulatory genome platform to
Walder Wyss advised SkyCell on its USD 116 million Series D financing round. It embarked on a USD 57 million equity investment by M&G Investments in October 2023 and has now been completed with further investments
Vischer advised Mininavident, located in Liestal, a developer and manufacturer of the world’s smallest dynamic navigation system for dental implant placement, which was acquired by the Straumann Group, a global leader in tooth replacement,
Homburger advised Danaher Corporation on its acquisition of Genedata, advised by Vischer, which on August 19th, 2024, announced that it had been acquired by Danaher Corporation (NYSE: DHR), a global life science and diagnostic innovator. Homburger
CMS has comprehensively advised Henry Schein, a provider of health care solutions to office-based dental and medical practitioners, on the acquisition of ABC Dental. MLL Legal advised ADMETOS on the sale of ABC Dental. The
Altenburger advised the Rey family with respect to the sale of a majority stake in the company REY Médical to Duomed group. This acquisition fits into Duomed’s strategy to grow as a distribution
An international CMS team under the lead of Stefan Brunnschweiler (pictured left) and Florian Jung (pictured right) provided comprehensive advice to Ypsomed on all legal aspects regarding the completion of the sale of its pen
